Juniper Publishers-Journal of Diabetes Obesity Journal

CURRENT RESEARCH IN DIABETES & OBESITY JOURNAL JUNIPER PUBLISHERS  Authored by Vinay Kumar Abstract Liraglutide is a glucagon like peptide-1 (GLP-1) analogue. GLP-1 is a potent inhibitor of motility and gastric emptying and has also been shown to inhibit gastric acid secretion. The inhibition of gastric emptying leads to decreased food intake and reduced body weight. The aim of the present study was to investigate the antiobesity effect of the Liraglutide on high fat diet (HFD) induced obesity in Wistar rats. Obesity was induced by oral feeding of HFD for six weeks. The antiobesity effect of Liraglutide (0.2mg/kg, i.p. for 14 days) in HFD fed rats was evaluated by the measurement of body mass index (BMI), body weight gain, food intake, hemodynamic changes (systolic, diastolic, mean blood pressure and heart rate), serum leptin, lipid profiles (triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol), glucose. Organ (Liver) and viscera

CURRENT RESEARCH IN DIABETES & OBESITY JOURNAL JUNIPER PUBLISHERS  Authored by Shaji Sreedhar KP   Abstract Ragi (Finger millet) is a traditional South Indian food, that is associated with various health benefits like reduction of cholesterol, obesity, diabetes, atherosclerosis and malnutrition. Despite its nutritional value and affordability, the usage of ragi is minimal when compared to oats, another nutritionally important cereal. In this study, the following were assessed: Knowledge of South Indian women aged 25-50 years about the nutritional benefits of ragi and oats. Attitude - the reasons for preferring oats over ragi. Practice - the usage frequency of ragi and oats. The study reveals that most of the people were ignorant about nutritional benefits of ragi in comparison to oats, an adopted food. The scores are above 6 out of 10 (mean score 7.5±1.1) for oats and less than 5 out of 10 (mean score 3±0.8) for ragi. The common reasons